Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

Inhibition of angiotensin II-induced cardiac hypertrophy and associated ventricular arrhythmias by a p21 activated kinase 1 bioactive peptide.

Wang R, Wang Y, Lin WK, Zhang Y, Liu W, Huang K, Terrar DA, Solaro RJ, Wang X, Ke Y, Lei M.

PLoS One. 2014 Jul 11;9(7):e101974. doi: 10.1371/journal.pone.0101974.

2.
3.

Pak1 as a novel therapeutic target for antihypertrophic treatment in the heart.

Liu W, Zi M, Naumann R, Ulm S, Jin J, Taglieri DM, Prehar S, Gui J, Tsui H, Xiao RP, Neyses L, Solaro RJ, Ke Y, Cartwright EJ, Lei M, Wang X.

Circulation. 2011 Dec 13;124(24):2702-15. doi: 10.1161/CIRCULATIONAHA.111.048785.

4.

Choline inhibits angiotensin II-induced cardiac hypertrophy by intracellular calcium signal and p38 MAPK pathway.

Wang S, Han HM, Pan ZW, Hang PZ, Sun LH, Jiang YN, Song HX, Du ZM, Liu Y.

Naunyn Schmiedebergs Arch Pharmacol. 2012 Aug;385(8):823-31. doi: 10.1007/s00210-012-0740-4.

PMID:
22569796
5.

19-Hydroxyeicosatetraenoic acid and isoniazid protect against angiotensin II-induced cardiac hypertrophy.

Elkhatali S, El-Sherbeni AA, Elshenawy OH, Abdelhamid G, El-Kadi AO.

Toxicol Appl Pharmacol. 2015 Dec 15;289(3):550-9. doi: 10.1016/j.taap.2015.10.003.

PMID:
26454030
6.

G1 cyclins are involved in the mechanism of cardiac myocyte hypertrophy induced by angiotensin II.

Nozato T, Ito H, Tamamori M, Adachi S, Abe S, Marumo F, Hiroe M.

Jpn Circ J. 2000 Aug;64(8):595-601.

7.

Novel EGFR inhibitors attenuate cardiac hypertrophy induced by angiotensin II.

Peng K, Tian X, Qian Y, Skibba M, Zou C, Liu Z, Wang J, Xu Z, Li X, Liang G.

J Cell Mol Med. 2016 Mar;20(3):482-94. doi: 10.1111/jcmm.12763.

8.

Adiponectin mediates cardioprotection in oxidative stress-induced cardiac myocyte remodeling.

Essick EE, Ouchi N, Wilson RM, Ohashi K, Ghobrial J, Shibata R, Pimentel DR, Sam F.

Am J Physiol Heart Circ Physiol. 2011 Sep;301(3):H984-93. doi: 10.1152/ajpheart.00428.2011.

9.

Dopamine D2 receptor stimulation inhibits angiotensin II-induced hypertrophy in cultured neonatal rat ventricular myocytes.

Li H, Shi S, Sun YH, Zhao YJ, Li QF, Li HZ, Wang R, Xu CQ.

Clin Exp Pharmacol Physiol. 2009 Mar;36(3):312-8. doi: 10.1111/j.1440-1681.2008.05064.x.

PMID:
18986329
11.

Soluble epoxide hydrolase plays an essential role in angiotensin II-induced cardiac hypertrophy.

Ai D, Pang W, Li N, Xu M, Jones PD, Yang J, Zhang Y, Chiamvimonvat N, Shyy JY, Hammock BD, Zhu Y.

Proc Natl Acad Sci U S A. 2009 Jan 13;106(2):564-9. doi: 10.1073/pnas.0811022106.

12.

Apoptosis signal-regulating kinase 1 plays a pivotal role in angiotensin II-induced cardiac hypertrophy and remodeling.

Izumiya Y, Kim S, Izumi Y, Yoshida K, Yoshiyama M, Matsuzawa A, Ichijo H, Iwao H.

Circ Res. 2003 Oct 31;93(9):874-83. Erratum in: Circ Res. 2016 Mar 4;118(5):e32.

13.

Peroxisome proliferator-activated receptor beta/delta activation improves angiotensin II-induced cardiac hypertrophy in vitro.

Sheng L, Ye P, Liu YX, Han CG, Zhang ZY.

Clin Exp Hypertens. 2008 Feb;30(2):109-19. doi: 10.1080/10641960801945840.

PMID:
18293166
14.

Actin dynamics is rapidly regulated by the PTEN and PIP2 signaling pathways leading to myocyte hypertrophy.

Li J, Tanhehco EJ, Russell B.

Am J Physiol Heart Circ Physiol. 2014 Dec 1;307(11):H1618-25. doi: 10.1152/ajpheart.00393.2014.

15.
16.

CIKS (Act1 or TRAF3IP2) mediates Angiotensin-II-induced Interleukin-18 expression, and Nox2-dependent cardiomyocyte hypertrophy.

Valente AJ, Clark RA, Siddesha JM, Siebenlist U, Chandrasekar B.

J Mol Cell Cardiol. 2012 Jul;53(1):113-24. doi: 10.1016/j.yjmcc.2012.04.009.

17.

SIRT1 functions as an important regulator of estrogen-mediated cardiomyocyte protection in angiotensin II-induced heart hypertrophy.

Shen T, Ding L, Ruan Y, Qin W, Lin Y, Xi C, Lu Y, Dou L, Zhu Y, Cao Y, Man Y, Bian Y, Wang S, Xiao C, Li J.

Oxid Med Cell Longev. 2014;2014:713894. doi: 10.1155/2014/713894.

18.

Knockdown of farnesylpyrophosphate synthase prevents angiotensin II-mediated cardiac hypertrophy.

Ye Y, Mou Y, Bai B, Li L, Chen GP, Hu SJ.

Int J Biochem Cell Biol. 2010 Dec;42(12):2056-64. doi: 10.1016/j.biocel.2010.09.010.

PMID:
20884373
19.

Regulation of L-type inward calcium channel activity by captopril and angiotensin II via the phosphatidyl inositol 3-kinase pathway in cardiomyocytes from volume-overload hypertrophied rat hearts.

Alvin Z, Laurence GG, Coleman BR, Zhao A, Hajj-Moussa M, Haddad GE.

Can J Physiol Pharmacol. 2011 Mar;89(3):206-15. doi: 10.1139/Y11-011.

20.

Inhibition of histone deacetylation blocks cardiac hypertrophy induced by angiotensin II infusion and aortic banding.

Kee HJ, Sohn IS, Nam KI, Park JE, Qian YR, Yin Z, Ahn Y, Jeong MH, Bang YJ, Kim N, Kim JK, Kim KK, Epstein JA, Kook H.

Circulation. 2006 Jan 3;113(1):51-9.

Supplemental Content

Support Center